George Health is a revenue generating, rapidly expanding global business which is poised for significant growth. It delivers attractive investment opportunities to bring life extending treatments to the world’s biggest killers.
George Health’s business model is focused on providing affordable, effective treatments for non-communicative diseases.
This number is growing as populations age, presenting a huge human and financial challenge to patients, health providers and
This is a significant market opportunity and George Health is responding to it rapidly. Its first treatment will be on the market by 2020.
George Health has exclusive access to the world-leading research and expertise of The George Institute, which has been at the forefront of innovative research for NCDs for two decades.
Investing in George Health provides long-term income opportunities with high growth potential, underwritten by an established profitable and expanding business.
George Health offers investors a chance to do good and earn strong returns, improving the lives of millions through innovative treatments for the world’s biggest killers.